accord astra pay cell $ 15 million
30 month research mileston reach cell
said initi phase collabor involv
preclin preliminari clinic studi product
compani ad cell said expect $ 1.5
million revenu astra third quarter
fiscal 1992 end today
astra may addit invest much $ 17 million
sever year follow initi phase
collabor cell said astra also may either fund
perform half addit develop joint
develop product compani said
cell said agreement astra exclus
world-wid market right product base
technolog cover agreement except market
right north america rheumatoid-arthr product
cell retain cell said also retain world-wid
manufactur right product receiv
percentag astra sale
